We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$25.3B
AUM Growth
+$814M
(+3.3%)
Cap. Flow
+$613M
Cap. Flow
% of AUM
2.42%
Top 10 Holdings %
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$31.9M |
| 2 |
Apple
AAPL
|
+$24.9M |
| 3 |
AT&T
T
|
+$21.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$20.2M |
| 5 |
Biogen
BIIB
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$34M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$22.2M |
| 3 |
HSBC
HSBC
|
+$20.3M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$19.9M |
| 5 |
CAJ
Canon, Inc.
CAJ
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.05% |
| 2 | Financials | 16.76% |
| 3 | Healthcare | 12.56% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
MGP Ingredients
MGPI
$379M
| $260K | ﹤0.01% |
5,233
+561
| +12% | +$31.5K |
|
2077
Designer Brands
DBI
$307M
| $259K | ﹤0.01% |
15,124
+3,520
| +30% | +$59.7K |
|
2078
Green Plains
GPRE
$1.18B
| $259K | ﹤0.01% |
24,452
+15,038
| +160% | +$144K |
|
2079
Heritage Financial
HFWA
$1.22B
| $259K | ﹤0.01% |
9,612
-1,048
| -10% | -$28.9K |
|
2080
Veeco
VECO
$3.05B
| $259K | ﹤0.01% |
22,133
+3,247
| +17% | +$36.6K |
|
2081
TriNet
TNET
$3.02B
| $258K | ﹤0.01% |
4,147
-333
| -7% | -$22.7K |
|
|
XLRN
2082
DELISTED
Acceleron Pharma
XLRN
| $258K | ﹤0.01% |
6,531
+1,906
| +41% | +$82.7K |
|
2083
Brookdale Senior Living
BKD
$3.49B
| $256K | ﹤0.01% |
33,746
+1,331
| +4% | +$10.5K |
|
|
RDUS
2084
DELISTED
Radius Health, Inc.
RDUS
| $256K | ﹤0.01% |
9,958
+617
| +7% | +$15.1K |
|
|
USCR
2085
DELISTED
U S Concrete, Inc.
USCR
| $256K | ﹤0.01% |
4,626
+644
| +16% | +$30.1K |
|
2086
First Merchants
FRME
$2.68B
| $255K | ﹤0.01% |
6,771
+631
| +10% | +$23.6K |
|
|
AERI
2087
DELISTED
Aerie Pharmaceuticals
AERI
| $255K | ﹤0.01% |
13,269
+5,496
| +71% | +$126K |
|
2088
Luxfer Holdings
LXFR
$456M
| $254K | ﹤0.01% |
16,297
-7,748
| -32% | -$142K |
|
2089
American Coastal Insurance
ACIC
$515M
| $250K | ﹤0.01% |
17,860
+13,715
| +331% | +$177K |
|
2090
Viasat
VSAT
$10.6B
| $250K | ﹤0.01% |
3,321
-1,822
| -35% | -$145K |
|
2091
Caesars Entertainment
CZR
$6.06B
| $249K | ﹤0.01% |
6,249
+502
| +9% | +$21.3K |
|
2092
Huron Consulting
HURN
$2.41B
| $249K | ﹤0.01% |
4,053
+373
| +10% | +$21.8K |
|
|
FINV
2093
FinVolution Group
FINV
$1.15B
| $248K | ﹤0.01% |
85,612
+79,535
| +1,309% | +$305K |
|
2094
Griffon
GFF
$3.95B
| $248K | ﹤0.01% |
11,836
+4,036
| +52% | +$72.1K |
|
2095
NVE Corp
NVEC
$562M
| $248K | ﹤0.01% |
3,743
+892
| +31% | +$60.8K |
|
|
DQ
2096
Daqo New Energy
DQ
$823M
| $246K | ﹤0.01% |
26,715
-2,880
| -10% | -$26.3K |
|
|
INFN
2097
DELISTED
Infinera Corporation Common Stock
INFN
| $246K | ﹤0.01% |
45,063
-12,387
| -22% | -$54.4K |
|
|
ISBC
2098
DELISTED
Investors Bancorp, Inc.
ISBC
| $246K | ﹤0.01% |
21,697
+3,875
| +22% | +$43.3K |
|
|
DBVT
2099
DBV Technologies
DBVT
$799M
| $245K | ﹤0.01% |
2,845
+995
| +54% | +$94.8K |
|
2100
Tronox
TROX
$932M
| $245K | ﹤0.01% |
29,485
-6,464
| -18% | -$62.3K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
- Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
- Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
- Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
- Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
- Aperio Group opened 5 new positions and closed 769 in Q3 2019.
- Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.
Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.